Human adult stem cells (hASCs) have become an attractive source for autologous cell transplantation, tissue engineering, developmental biology, and the generation of human-based alternative in vitro models. Among the 3 germ cell layers, the mesoderm is the origin of today's most widely used and characterized hASC populations. A variety of isolated nonhematopoietic mesoderm-derived stem cell populations exist, and all of them show important differences in terms of function, efficacy, and differentiation potential both in vivo and in vitro. To better understand whether the intrinsic properties of these cells contribute to the overall differentiation potential of hASCs, we compared the global gene expression profiles of 4 mesoderm-derived stem cell populations: human adipose tissue-derived stromal cells, human bone marrow-derived stromal cells (hBMSCs), human (fore)skin-derived precursor cells (hSKPs), and human Wharton's jelly-derived mesenchymal stem cells (hWJs). Significant differences in gene expression profiles were detected between distinct stem cell types. hSKPs predominantly expressed genes involved in neurogenesis, skin, and bone development, whereas hWJs and, to some extent, hBMSCs showed an increased expression of genes involved in cardiovascular and liver development. Interestingly, the observed differential gene expression of distinct hASCs could be linked to existing differentiation data in which hASCs were differentiated toward specific cell types. As such, our data suggest that the intrinsic gene expression of the undifferentiated stem cells has an important impact on their overall differentiation potential as well as their application in stem cell-based research. Yet, the factors that define these intrinsic properties remain to be determined.
Get full access to this article
View all access options for this article.
References
1.
FerrariG, Cusella-De AngelisG, ColettaM, PaolucciE, StornaiuoloA, CossuG, MavilioF. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science, 279:1528–1530.
2.
SnykersS, VanhaeckeT, De BeckerA, PapeleuP, VinkenM, Van RietI, RogiersV. 2007. Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow. BMC Dev Biol, 7:24.
JinnoH, MorozovaO, JonesKL, BiernaskieJA, ParisM, HosokawaR, RudnickiMA, ChaiY, RossiF, MarraMA, MillerFD. 2010. Convergent genesis of an adult neural crest-like dermal stem cell from distinct developmental origins. Stem Cells, 28:2027–2040.
5.
De KockJ, VanhaeckeT, BiernaskieJ, RogiersV, SnykersS. 2009. Characterization and hepatic differentiation of skin-derived precursors from adult foreskin by sequential exposure to hepatogenic cytokines and growth factors reflecting liver development. Toxicol In Vitro, 23:1522–1527.
6.
De KockJ, SnykersS, RamboerE, DemeesterS, HeymansA, BransonS, VanhaeckeT, RogiersV. 2011. Evaluation of the multipotent character of human foreskin-derived precursor cells. Toxicol In Vitro, 25:1191–1202.
7.
Al BattahF, De KockJ, RamboerE, HeymansA, VanhaeckeT, RogiersV, SnykersS. 2011. Evaluation of the multipotent character of human adipose tissue-derived stem cells isolated by Ficoll gradient centrifugation and red blood cell lysis treatment. Toxicol In Vitro, 25:1224–1230.
8.
BeltramiAP, CesselliD, BergaminN, MarconP, RigoS, PuppatoE, D'AurizioF, VerardoR, PiazzaSet al. 2007. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow)Blood, 110:3438–3446.
9.
D'IppolitoG, DiabiraS, HowardGA, MeneiP, RoosBA, SchillerPC. 2004. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci, 117,Pt 14:2971–2981.
10.
KuciaM, RecaR, CampbellFR, Zuba-SurmaE, MajkaM, RatajczakJ, RatajczakMZ. 2006. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia, 20:857–869.
11.
SohniA, VerfaillieCM. 2011. Multipotent adult progenitor cells. Best Pract Res Clin Haematol, 24,1:3–11.
12.
WojakowskiW, TenderaM, KuciaM, Zuba-SurmaE, MilewskiK, Wallace-BradleyD, KazmierskiM, BuszmanP, HrycekEet al. 2010. Cardiomyocyte differentiation of bone marrow-derived Oct-4+CXCR4+SSEA-1+ very small embryonic-like stem cells. Int J Oncol, 37:237–247.
13.
JonesBJ, McTaggartSJ. 2008. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol, 36:733–741.
14.
NirmalanandhanVS, SittampalamGS. 2009. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges. J Biomol Screen, 14:755–768.
UccelliA, LaroniA, FreedmanMS. 2011. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol, 10:649–656.
17.
FongCY, SubramanianA, BiswasA, GauthamanK, SrikanthP, HandeMP, BongsoA. 2010. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod Biomed Online, 21:391–401.
18.
VodyanikMA, YuJ, ZhangX, TianS, StewartR, ThomsonJA, SlukvinII. 2010. A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell, 7:718–729.
LavoieJF, BiernaskieJA, ChenY, BagliD, AlmanB, KaplanDR, MillerFD. 2009. Skin-derived precursors differentiate into skeletogenic cell types and contribute to bone repair. Stem Cells Dev, 18:893–906.
21.
WangL, ZhaoL, DetamoreMS. 2011. Human umbilical cord mesenchymal stromal cells in a sandwich approach for osteochondral tissue engineering. J Tissue Eng Regen Med, 5:712–721.
22.
MuracaM. 2011. Evolving concepts in cell therapy of liver disease and current clinical perspectives. Dig Liver Dis, 43:180–187.
23.
TitomanlioL, KavelaarsA, DalousJ, ManiS, El GhouzziV, HeijnenC, BaudO, GressensP. 2011. Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann Neurol, 70:698–712.
Guguen-GuillouzoC, CorluA, GuillouzoA. 2010. Stem cell-derived hepatocytes and their use in toxicology. Toxicology, 270:3–9.
26.
NajarM, RaicevicG, Id BoufkerH, StamatopoulosB, De BruynC, MeulemanN, BronD, ToungouzM, LagneauxL. 2010. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Exp Hematol, 38:922–932.
27.
De BruynC, NajarM, RaicevicG, MeulemanN, PietersK, StamatopoulosB, DelforgeA, BronD, LagneauxL. 2011. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev, 20:547–557.
BolstadBM, IrizarryRA, AstrandM, SpeedTP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 19:185–193.
30.
GautierL, CopeL, BolstadBM, IrizarryRA. 2004. affy—analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, 20:307–315.
31.
PepperSD, SaundersEK, EdwardsLE, WilsonCL, MillerCJ. 2007. The utility of MAS5 expression summary and detection call algorithms. BMC Bioinformatics, 8:273.
32.
WardJ. 1963. Hierarchical grouping to optimize an objective function. J Am Stat Assoc, 58:236–244.
33.
ScanuM, MancusoL, CaoG. 2011. Evaluation of the use of human Mesenchymal Stem Cells for acute toxicity tests. Toxicol In Vitro, 25:1989–1995.
34.
JansenBJ, GilissenC, RoelofsH, Schaap-OziemlakA, VeltmanJA, RaymakersRA, JansenJH, KöglerG, FigdorCGet al. 2010. Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev, 19:481–490.
35.
BoquestAC, NoerA, CollasP. 2006. Epigenetic programming of mesenchymal stem cells from human adipose tissue. Stem Cell Rev, 2:319–329.
AurichH, SgoddaM, KaltwasserP, VetterM, WeiseA, LiehrT, BrulportM, HengstlerJG, DollingerMM, FleigWE, ChristB. 2009. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut, 58:570–581.
38.
ChoiYS, DustingGJ, StubbsS, ArunothayarajS, HanXL, CollasP, MorrisonWA, DilleyRJ. 2010. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J Cell Mol Med, 14:878–889.
39.
RosenV. 2009. BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev, 20:475–480.
40.
NauthA, RistevskiB, LiR, SchemitschEH. 2011. Growth factors and bone regeneration: how much bone can we expect?Injury, 42:574–579.
41.
KurodaR, UsasA, KuboS, CorsiK, PengH, RoseT, CumminsJ, FuFH, HuardJ. 2006. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum, 54:433–442.
42.
MiljkovicND, CooperGM, MarraKG. 2008. Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis Cartilage, 16:1121–1130.
43.
WuM, LiJ, EnglekaKA, ZhouB, LuMM, PlotkinJB, EpsteinJA. 2008. Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice. J Clin Invest, 118:2076–2087.
44.
BildsoeH, LoebelDA, JonesVJ, ChenYT, BehringerRR, TamPP. 2009. Requirement for Twist1 in frontonasal and skull vault development in the mouse embryo. Dev Biol, 331:176–188.
45.
DanciuTE, LiY, KohA, XiaoG, McCauleyLK, FranceschiRT. 2012. The basic helix loop helix transcription factor Twist1 is a novel regulator of ATF4 in osteoblasts. J Cell Biochem, 113:70–79.
46.
KomoriT. 2011. Signaling networks in RUNX2-dependent bone development. J Cell Biochem, 112:750–755.
47.
ChungIH, HanJ, IwataJ, ChaiY. 2010. Msx1 and Dlx5 function synergistically to regulate frontal bone development. Genesis, 48:645–655.
48.
RoybalPG, WuNL, SunJ, TingMC, SchaferCA, MaxsonRE. 2010. Inactivation of Msx1 and Msx2 in neural crest reveals an unexpected role in suppressing heterotopic bone formation in the head. Dev Biol, 343:28–39.
49.
MedicS, RizosH, ZimanM. 2011. Differential PAX3 functions in normal skin melanocytes and melanoma cells. Biochem Biophys Res Commun, 411:832–837.
50.
WangWD, MelvilleDB, Montero-BalaguerM, HatzopoulosAK, KnapikEW. 2011. Tfap2a and Foxd3 regulate early steps in the development of the neural crest progenitor population. Dev Biol, 360:173–185.
51.
BiernaskieJ, SparlingJS, LiuJ, ShannonCP, PlemelJR, XieY, MillerFD, TetzlaffW. 2007. Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J Neurosci, 27:9545–9559.
52.
BiernaskieJ, MillerFD. 2010. White matter repair: skin-derived precursors as a source of myelinating cells. Can J Neurol Sci, 37,Suppl 2:S34–S41.
53.
FernandesKJ, KobayashiNR, GallagherCJ, Barnabé-HeiderF, AumontA, KaplanDR, MillerFD. 2006. Analysis of the neurogenic potential of multipotent skin-derived precursors. Exp Neurol, 201:32–48.
54.
HigashidaT, JitsukiS, KuboA, MitsushimaD, KamiyaY, KannoH. 2010. Skin-derived precursors differentiating into dopaminergic neuronal cells in the brains of Parkinson disease model rats. J Neurosurg, 113:648–655.
55.
McKenzieIA, BiernaskieJ, TomaJG, MidhaR, MillerFD. 2006. Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J Neurosci, 26:6651–6660.
56.
Le DouarinNM, CalloniGW, DupinE. 2008. The stem cells of the neural crest. Cell Cycle, 7:1013–1019.
57.
KopenGC, ProckopDJ, PhinneyDG. 1999. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A, 96:10711–10716.
58.
WoodburyD, SchwarzEJ, ProckopDJ, BlackIB. 2000. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res, 61:364–370.
59.
HofstetterCP, SchwarzEJ, HessD, WidenfalkJ, El ManiraA, ProckopDJ, OlsonL. 2002. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A, 99:2199–2204.
60.
DattaI, MishraS, MohantyL, PulikkotS, JoshiPG. 2011. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells. Cytotherapy, 13:918–932.
61.
RomanovYA, DarevskayaAN, MerzlikinaNV, BuravkovaLB. 2005. Mesenchymal stem cells from human bone marrow and adipose tissue: isolation, characterization, and differentiation potentialities. Bull Exp Biol Med, 140:138–143.
62.
SaffordKM, HicokKC, SaffordSD, HalvorsenYD, WilkisonWO, GimbleJM, RiceHE. 2002. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun, 294:371–379.
63.
AboodyK, CapelaA, NiaziN, SternJH, TempleS. 2001. Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta Stone. Neuron, 70:597–613.
64.
NassiriF, CusimanoMD, ScheithauerBW, RotondoF, FazioA, YousefGM, SyroLV, KovacsK, LloydRV. 2011. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res, 31:2283–2290.
65.
ZhangY, KanterEM, YamadaKA. 2010. Remodeling of cardiac fibroblasts following myocardial infarction results in increased gap junction intercellular communication. Cardiovasc Pathol, 19:e233–e240.
66.
UosakiH, FukushimaH, TakeuchiA, MatsuokaS, NakatsujiN, YamanakaS, YamashitaJK. 2011. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One, 6:e23657.
WakitaniS, SaitoT, CaplanAI. 1995. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 18:1417–1426.
69.
OskowitzA, McFerrinH, GutschowM, CarterML, PochampallyR. 2011. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res, 6:215–225.
70.
VincentzJW, BarnesRM, FirulliAB. 2011. Hand factors as regulators of cardiac morphogenesis and implications for congenital heart defects. Birth Defects Res A Clin Mol Teratol, 91:485–494.
Martin-RendonE, SweeneyD, LuF, GirdlestoneJ, NavarreteC, WattSM. 2008. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang, 95:137–148.
73.
PereiraWC, KhushnoomaI, MadkaikarM, GhoshK. 2008. Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation. J Tissue Eng Regen Med, 2:394–399.
74.
WangHS, HungSC, PengST, HuangCC, WeiHM, GuoYJ, FuYS, LaiMC, ChenCC. 2004. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 22:1330–1337.
75.
AlaminosM, Pérez-KöhlerB, GarzónI, García-HonduvillaN, RomeroB, CamposA, BujánJ. 2010. Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells. J Cell Physiol, 223:640–647.
76.
Si-TayebK, LemaigreFP, DuncanSA. 2010. Organogenesis and development of the liver. Dev Cell, 18:175–189.
77.
SatoN, YamabukiT, TakanoA, KoinumaJ, AragakiM, MasudaK, IshikawaN, KohnoN, ItoHet al. 2010. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res, 70:5326–5336.
78.
CostelloI, BiondiCA, TaylorJM, BikoffEK, RobertsonEJ. 2009. Smad4-dependent pathways control basement membrane deposition and endodermal cell migration at early stages of mouse development. BMC Dev Biol, 9:54.
79.
NavaP, LaukoetterMG, HopkinsAM, LaurO, Gerner-SmidtK, GreenKJ, ParkosCA, NusratA. 2007. Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell, 18:4565–4578.
80.
LiZ, KorzhV, GongZ. 2007. Localized rbp4 expression in the yolk syncytial layer plays a role in yolk cell extension and early liver development. BMC Dev Biol, 7:117.
81.
ParkJE, KimHT, LeeS, LeeYS, ChoiUK, KangJH, ChoiSY, KangTC, ChoiMS, KwonOS. 2011. Differential expression of intermediate filaments in the process of developing hepatic steatosis. Proteomics, 11:2777–2789.
82.
OkadaK, KamiyaA, ItoK, YanagidaA, ItoH, KondouH, NishinaH, NakauchiH. 2012. Prospective isolation and characterization of bipotent progenitor cells in early mouse liver development. Stem Cells Dev, 21:1124–1133.
YoonHH, JungBY, SeoYK, SongKY, ParkJK. 2010. In vitro hepatic differentiation of umbilical cord-derived mesenchymal stem cell. Process Biochem, 45:1857–1864.
85.
ZhangYN, LiePC, WeiX. 2009. Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells. Cytotherapy, 11:548–558.
86.
AnzaloneR, Lo IaconoM, CorraoS, MagnoF, LoriaT, CappelloF, ZummoG, FarinaF, La RoccaG. 2010. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev, 19:423–438.
87.
SeoMJ, SuhSY, BaeYC, JungJS. 2005. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun, 328:258–264.
88.
SgoddaM, AurichH, KleistS, AurichI, KönigS, DollingerMM, FleigWE, ChristB. 2007. Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res, 313:2875–2886.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
